Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men

The serotonin 5-HT6receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease

(2009) Werner J Geldenhuys et al.   Expert Review of Neurotherapeutics

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects

(2009) M Liem-Moolenaar et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects

(2009) SL de Haas et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol

(2008) M. Liem-Moolenaar et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effect of intrapulmonary tetrahydrocannabinol administration in humans

(2008) L. Zuurman et al.   JOURNAL OF PSYCHOPHARMACOLOGY

5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer’s disease

(2008) Neil Upton et al.   Neurotherapeutics